Skylands Capital’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.02M Buy
4,025
+200
+5% +$96K 0.25% 82
2026
Q1
$1.88M Buy
+3,825
New +$2.08M 0.25% 85
2025
Q4
Sell
-2,050
Closed -$994K 159
2025
Q3
$994K Sell
2,050
-1,300
-39% -$605K 0.14% 104
2025
Q2
$1.36M Buy
+3,350
New +$1.4M 0.2% 90

Other funds holding TMO

Skylands Capital's TMO Position: Q2 2026 in Review

Skylands Capital increased its Thermo Fisher Scientific (TMO) stake by 5.2% in Q2 2026, buying an estimated $96K and bringing the position to 4,025 shares worth $2.02M. The position accounts for 0.25% of the portfolio, ranked #82.

Skylands Capital first reported a position in TMO in Q2 2025 and has held it in 4 quarters since. 954 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Skylands Capital held 4,025 shares of Thermo Fisher Scientific worth $2.02M as of Q2 2026.
  • Skylands Capital bought 200 Thermo Fisher Scientific shares in Q2 2026, an estimated $96K.
  • Thermo Fisher Scientific made up 0.25% of Skylands Capital's portfolio in Q2 2026, its #82 holding.
  • Skylands Capital first reported a position in Thermo Fisher Scientific in Q2 2025 and has held it in 4 quarters since.
  • 954 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Skylands Capital's 13F filing for Q2 2026, filed 24 Jul 2026.